Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOA | P21397 | 3/20 | 0.54 |
| ▸ | MAOB | P27338 | 3/20 | 0.54 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.54 |
| ▸ | CA12 | O43570 | 3/20 | 0.53 |
| ▸ | CA9 | Q16790 | 3/20 | 0.53 |
| ▸ | CA2 | P00918 | 2/20 | 0.53 |
| ▸ | CA1 | P00915 | 2/20 | 0.53 |
| ▸ | CA4 | P22748 | 2/20 | 0.53 |
| ▸ | GSTP1 | P09211 | 1/20 | 0.53 |
| ▸ | CA7 | P43166 | 1/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.47 |
| ▸ | LMNA | P02545 | 2/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
| ▸ | HPGD | P15428 | 1/20 | 0.47 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.45 |
| ▸ | HDAC3 | O15379 | 2/20 | 0.45 |
| ▸ | HDAC2 | Q92769 | 2/20 | 0.45 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20305460 | 0.88 | CYP19A1 (0.54) | MAOAMAOBPTGS2CA12CA9 | |
| SCHEMBL20305350 | 0.87 | PTGS2 (0.45) | MAOAMAOBPTGS2CA12CA9 | |
| SCHEMBL23315105 | 0.84 | CA12 (0.54) | MAOAMAOBPTGS2CA12CA9 | |
| SCHEMBL10690394 | 0.83 | ALDH1A1 (0.50) | ALDH1A1SMN1; SMN2LMNAMAPTHPGD | |
| SCHEMBL31286481 | 0.83 | ALDH1A1 (0.47) | MAOAMAOBPTGS2CA12CA9 | |
| SCHEMBL16585081 | 0.83 | ALDH1A1 (0.51) | MAOAMAOBPTGS2CA12CA9 | |
| SCHEMBL19952676 | 0.83 | ALDH1A1 (0.47) | MAOAMAOBPTGS2CA12CA9 | |
| SCHEMBL5704167 | 0.82 | CA12 (0.63) | MAOAMAOBPTGS2CA12CA9 | |
| SCHEMBL31233273 | 0.82 | MAOB (0.49) | MAOAMAOBPTGS2CA12CA9 | |
| SCHEMBL8011907 | 0.82 | ALDH1A1 (0.49) | ALDH1A1SMN1; SMN2LMNAMAPTHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 204 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119504863-A | Phosphaphenanthrene-containing compound, epoxy resin material, and preparation methods and applications thereof | 岭南师范学院 | 2025-02-25 | — | — | CN | claimed |
| CN-116004030-B | Azamethylenedipyrrole metal complex dye based on click chemistry, and preparation method and application thereof | 天津大学 | 2024-08-16 | — | — | CN | claimed |
| CN-116004030-A | Azamethylenedipyrrole metal complex dye based on click chemistry, and preparation method and application thereof | 天津大学 | 2023-04-25 | — | — | CN | claimed |
| WO-2014073003-A1 | SINGLE-STEP PROCESS FOR THE PREPARATION OF ARYL OLEFINS | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2014-05-15 | — | — | WO | claimed |
| US-12584023-B2 | Composition for forming organic film, patterning process, and compound | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2026-03-24 | — | — | US | disclosed |
| EP-4239408-B1 | COMPOSITION FOR FORMING ORGANIC FILM, PATTERNING PROCESS, AND COMPOUND | SHINETSU CHEMICAL CO (JP) | 2025-12-10 | — | — | EP | disclosed |
| US-20250354195-A1 | METHOD OF SCREENING | UNIV DUNDEE (GB) | 2025-11-20 | — | — | US | disclosed |
| EP-3759075-B1 | COMPOUNDS WITH FERROPTOSIS INDUCING ACTIVITY AND METHODS OF THEIR USE | FERRO THERAPEUTICS INC (US) | 2025-07-23 | — | — | EP | disclosed |
| US-20250188110-A1 | SPECIFIC SMALL MOLECULE INHIBITORS THAT BLOCK KMT9 METHYLTRANSFERASE ACTIVITY AND FUNCTION | ALBERT-LUDWIGS-UNIVERSITÄT FREIBURG (DE) | 2025-06-12 | — | — | US | disclosed |
| US-20250129101-A1 | Compound, Pharmaceutical Composition Comprising the Same and Method for Treating Cancer Using the Same | NATIONAL TSING HUA UNIVERSITY (TW) | 2025-04-24 | — | — | US | disclosed |
| CN-119504863-A | Phosphaphenanthrene-containing compound, epoxy resin material, and preparation methods and applications thereof | 岭南师范学院 | 2025-02-25 | — | — | CN | disclosed |
| US-20250011330-A1 | Imidazo[1,2- a]pyrazine and Imidazo[1,2- a]pyridine Based Tyrosyl-DNA Phosphodiesterase I (TDP1) Inhibitors | LEIDOS BIOMEDICAL RESEARCH INC. | 2025-01-09 | — | — | US | disclosed |
| US-4654344-A | ALSO AFFECT BLOOD PRESSURE AND MYOCARDIAL CONTRACTIONS | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 1987-03-31 | — | — | US | disclosed |
| EP-0093951-B1 | 2-ARYL-TETRAAZAINDENES | MERCK PATENT GmbH (DE) | 1986-10-29 | — | — | EP | disclosed |
| US-4616090-A | 2-arylimidazopyridines intermediates | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 1986-10-07 | — | — | US | disclosed |
| EP-0072926-B1 | 2-ARYLIMIDAZOPYRIDINES | MERCK PATENT GmbH (DE) | 1986-09-24 | — | — | EP | disclosed |
| US-4575505-A | Pharmaceutical compositions containing 2-aryltetraazaindenes for treating ulcers or cardiac insufficiency or blood pressure abnormalities | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 1986-03-11 | — | — | US | disclosed |
| US-4477454-A | INDOTROPIC AGENTS | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 1984-10-16 | — | — | US | disclosed |
| EP-0093951-A2 | 2-Aryl-tetraazaindenes | MERCK PATENT GmbH (DE) | 1983-11-16 | — | — | EP | disclosed |
| EP-0072926-A1 | 2-Arylimidazopyridines | MERCK PATENT GmbH (DE) | 1983-03-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250188110-A1 | SPECIFIC SMALL MOLECULE INHIBITORS THAT BLOCK KMT9 METHYLTRANSFERASE ACTIVITY AND FUNCTION | KMT5A, KMT5B, KMT5C | MAOA 1069/4885MAOB 648/4885PTGS2 4339/4885 |
| US-20250129101-A1 | Compound, Pharmaceutical Composition Comprising the Same and Method for Treating Cancer Using the Same | RB1, TP53, ASH2L | MAOA 3440/4885MAOB 2756/4885PTGS2 2070/4885 |
| US-20250011330-A1 | Imidazo[1,2- a]pyrazine and Imidazo[1,2- a]pyridine Based Tyrosyl-DNA Phosphodiesterase I (TDP1) Inhibitors | TDP1, TDP2, TOP1 | MAOA 1115/4885MAOB 1589/4885PTGS2 2281/4885 |
| US-12584023-B2 | Composition for forming organic film, patterning process, and compound | F12, MLX, F11 | MAOA 2691/4885MAOB 3131/4885PTGS2 1935/4885 |
| US-20250354195-A1 | METHOD OF SCREENING | PAICS, COASY, ABCG2 | MAOA 63/4885MAOB 27/4885PTGS2 3104/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.